Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Research use only Supplied exclusively for laboratory investigation and development
Not approved for human use, not for therapeutic applications, and not for in vivo studies in humans
Capsules are more convenient, but injection requires reconstitution and sterile supplies
This formulation combines Cartalax, TB-500, and BPC-157 into a single research blend, providing researchers with a valuable tool for examining coordinated peptide signaling, pathway convergence, and complementary mechanisms involved in tissue organization and extracellular matrix regulation within controlled laboratory environments
In the UK, BPC-157 has no MHRA marketing authorisation, so any sale or supply for human therapeutic use falls into the category of unlicensed medicine and sits outside standard legal and professional frameworks
)
)
US$ 20.24
US$ 27.57
US$ 26.15
US$ 28.35
US$ 26.76
US$ 21.88
US$ 27.46
US$ 24.96
